In conclusion, our study showed for the first time that pseudogene DUXAP10 expression is up-regulated in NSCLC tissues and cells, indicating that its overexpression may be a negative prognostic factor for NSCLC patients. Here, DUXAP10 is linked to non-small cell lung carcinoma.